Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I A Cooper

Showing results (21-30 of 69) with videos related to

Pageof 7
Sort By:
European Journal of Cancer|February 1, 1981
An explanation for the S-phase specificity of the cytotoxicity of protein synthesis inhibitorsD M Woodcock, J K Adams, I A Cooper
Cancer Research|April 1, 1979
Evidence for a new mechanism of cytotoxicity of 1-beta-D arabinofuranosylcytosineD M Woodcock, R M Fox, I A Cooper
Journal of Clinical Pathology|August 1, 1990
Value of bilateral bone marrow biopsy specimens in non-Hodgkin's lymphomaS K Juneja, M M Wolf, I A Cooper
Postgraduate Medical Journal|June 1, 1987
Nocardia infection in splenectomized patients: case reports and a review of the literatureE A Abdi, J C Ding, I A Cooper
Lancet (London, England)|August 9, 1975
Splenectomy for haematological cytopenias in patients with malignant lymphomasP J Morris, I A Cooper, J P Madigan
Australian and New Zealand Journal of Medicine|April 1, 1987
Abdominal CT and lymphography in the initial staging of non-Hodgkin's lymphomaW J Benson, J C Ding, I A Cooper
Cancer Research|September 1, 1985
Biology of cell killing by 1-beta-D-arabinofuranosylcytosine and its relevance to molecular mechanisms of cytotoxicityP J Crowther, I A Cooper, D M Woodcock
European Journal of Cancer|November 1, 1977
Urinary excretory patterns of tRNA degradation products: a marker of Hodgkin's cell metabolism?I A Cooper, G R Wray, T L Murphy
Biochimica Et Biophysica Acta|January 26, 1982
Characteristics of enzymatic DNA methylation in cultured cells of human and hamster origin, and the effect of DNA replication inhibitionD M Woodcock, J K Adams, I A Cooper
Cancer|May 1, 1975
Thymic origin of abnormal lymphoid cells in Sézary syndromeJ C Ding, P B Adams, M Patison, et al.
Pageof 7

Showing results (21-30 of 69) with videos related to

Sort By:
Pageof 7
European Journal of Cancer|February 1, 1981
An explanation for the S-phase specificity of the cytotoxicity of protein synthesis inhibitorsD M Woodcock, J K Adams, I A Cooper
Cancer Research|April 1, 1979
Evidence for a new mechanism of cytotoxicity of 1-beta-D arabinofuranosylcytosineD M Woodcock, R M Fox, I A Cooper
Journal of Clinical Pathology|August 1, 1990
Value of bilateral bone marrow biopsy specimens in non-Hodgkin's lymphomaS K Juneja, M M Wolf, I A Cooper
Postgraduate Medical Journal|June 1, 1987
Nocardia infection in splenectomized patients: case reports and a review of the literatureE A Abdi, J C Ding, I A Cooper
Lancet (London, England)|August 9, 1975
Splenectomy for haematological cytopenias in patients with malignant lymphomasP J Morris, I A Cooper, J P Madigan
Australian and New Zealand Journal of Medicine|April 1, 1987
Abdominal CT and lymphography in the initial staging of non-Hodgkin's lymphomaW J Benson, J C Ding, I A Cooper
Cancer Research|September 1, 1985
Biology of cell killing by 1-beta-D-arabinofuranosylcytosine and its relevance to molecular mechanisms of cytotoxicityP J Crowther, I A Cooper, D M Woodcock
European Journal of Cancer|November 1, 1977
Urinary excretory patterns of tRNA degradation products: a marker of Hodgkin's cell metabolism?I A Cooper, G R Wray, T L Murphy
Biochimica Et Biophysica Acta|January 26, 1982
Characteristics of enzymatic DNA methylation in cultured cells of human and hamster origin, and the effect of DNA replication inhibitionD M Woodcock, J K Adams, I A Cooper
Cancer|May 1, 1975
Thymic origin of abnormal lymphoid cells in Sézary syndromeJ C Ding, P B Adams, M Patison, et al.
Pageof 7